Recent Advances Towards Selenium Nanoparticles: Synthetic Methods, Functional Mechanisms, and Biological Applications
Geng L., Li L., Sun X., Cheng S., He J.
Narrative Review, published in Foods (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Foods (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41227614
- PMCID
- PMC12607590
- DOI
- 10.3390/foods14213640
- Citations
- 5
Abstract (original English)
The exceptional physicochemical properties of selenium nanoparticles (SeNPs) have led to their widespread development. The function of SeNPs is significantly influenced by their shape and particle size, which are in turn determined by the applied synthesis methods. This work presents a critical and comparative analysis of physical, chemical, and biosynthetic methods. The key point is to elaborate on how different methods precisely regulate the particle size, morphology, and stability that are crucial to their functional efficacy. This work emphasizes the importance of creating standardized protocols for characterizing SeNPs in order to make meaningful comparisons between the effectiveness of various studies. We further elucidate the underlying mechanisms of SeNPs' anti-tumor, antioxidant, and antibacterial activities. A key novelty of this work lies in its systematic construction of a bridge between the synthesis, properties, functions, applications, and translational potential and its provision of a critical assessment. Finally, the review identifies and summarizes the principal challenges hindering clinical and commercial translation, including the imperative for standardized toxicological evaluation, scalable synthesis, and regulatory alignment.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.